Clinical Trial

ASPIRIN Trial Belgium

Name: ASPIRIN Trial Belgium — clinical trial record (NCT03464305)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Study acronym: ASPIRIN

Active, Not Recruiting Phase 3

View on ClinicalTrials.gov →

Summary

The purpose of this study is to determine whether acetylsalicylic acid is effective on the recurrence and survival of colon cancer patients.

Protocol Amendment History 5 amendments

This ClinicalTrials.gov record has been amended 5 times since 2018-03-07; most recent amendment 2024-03-16.

Status change: Recruiting → Active, Not Recruiting 2024-03-16

Trial Details

NCT Number	NCT03464305
Lead Sponsor	University Hospital, Antwerp Collaborators: Kom Op Tegen Kanker, Anticancerfund
Conditions	Colon Cancer
Enrollment	148 participants
Start Date	2018-02-22
Primary Completion	2027-12-31 (estimated)
Study Completion	2027-12-31 (estimated)
Updated on ClinicalTrials.gov	2024-03-19